In Silico Identification of New Targets for Diagnosis, Vaccine, and Drug Candidates against Trypanosoma cruzi

Table 5

Prediction of the MHC II binding.

Allele	Protein access	Size (start-end)	Peptide	Rank
HLA-DRB501:01	PRFA01000041	487-501	AENMFMSLFSGAKHE	0.01
HLA-DRB501:01	PRFA01000041	488-502	ENMFMSLFSGAKHEK	0.01
HLA-DRB501:01	PRFA01000041	489-503	NMFMSLFSGAKHEKS	0.01
HLA-DRB301:01	ADWP02002940	72-86	VLTCSLFMIATTYYF	0.01
HLA-DRB301:01	ADWP02002940	73-87	LTCSLFMIATTYYFA	0.01
HLA-DRB301:01	ADWP02002940	74-88	TCSLFMIATTYYFAV	0.01
HLA-DRB301:01	ADWP02002940	75-89	CSLFMIATTYYFAVY	0.01
HLA-DRB301:01	ADWP02002940	76-90	SLFMIATTYYFAVYK	0.01
HLA-DRB301:01	ADWP02002940	77-91	LFMIATTYYFAVYKQ	0.01
HLA-DRB301:01	ADWP02002940	78-92	FMIATTYYFAVYKQC	0.01
HLA-DRB301:01	MBSY01000777	139-153	SCAGFLFITMFLFYA	0.02
HLA-DRB301:01	MBSY01000777	140-154	CAGFLFITMFLFYAL	0.02
HLA-DRB301:01	MBSY01000777	141-155	AGFLFITMFLFYALS	0.02
HLA-DRB301:01	MBSY01000777	217-231	PPFLLLFMPMFVAAM	0.02
HLA-DRB301:01	PRFA01000041	1518-1532	ELEGSMIDLDAEVSI	0.02
HLA-DRB301:01	PRFA01000041	1519-1533	LEGSMIDLDAEVSIP	0.02
HLA-DRB301:01	PRFA01000041	1520-1534	EGSMIDLDAEVSIPQ	0.02
HLA-DRB301:01	PRFA01000041	1521-1535	GSMIDLDAEVSIPQQ	0.02
HLA-DRB301:01	PRFA01000041	1522-1536	SMIDLDAEVSIPQQK	0.02
HLA-DRB501:01	PRFA01000041	486-500	HAENMFMSLFSGAKH	0.02
HLA-DRB501:01	PRFA01000041	490-504	MFMSLFSGAKHEKSR	0.02
HLA-DRB501:01	PRFA01000041	491-505	FMSLFSGAKHEKSRN	0.02
HLA-DRB107:01	MBSY01000212	299-313	DCWVKEYVTASATMI	0.03
HLA-DRB301:01	PRFA01000041	600-614	STALHAIPWDQRAFI	0.03
HLA-DRB301:01	PRFA01000041	601-615	TALHAIPWDQRAFIP	0.03
HLA-DRB301:01	PRFA01000041	602-616	ALHAIPWDQRAFIPI	0.03
HLA-DRB301:01	PRFA01000041	603-617	LHAIPWDQRAFIPIS	0.03
HLA-DRB301:01	PRFA01000041	604-618	HAIPWDQRAFIPISG	0.03
HLA-DRB301:01	PRFA01000041	1108-1122	RRLILYIAVAILSFL	0.03
HLA-DRB115:01	ADWP02002940	272-286	VFAVMLFGSIFVTLL	0.03